News | January 04, 2010

New Embolic Defector Used in First Clinical Experience

January 5, 2010 – St. Paul’s Hospital in Vancouver, Canada recently was the first to use the Embrella Embolic Deflector cerebral protection system. The device uses a porous membrane to deflect emboli away from the carotid arteries. It is inserted through the right radial or right brachial artery, away from the femoral artery, which is the typical access site for procedures. The device was used in a 91-year-old patient undergoing a balloon aortic valvuloplasty (BAV) procedure. During BAV procedures there is a risk that atheromatous plaque may be dislodged and travel to the brain during the passage of catheters around the aortic arch or during the subsequent balloon dilation of the stenotic and calcified aortic valve. The device was inserted through the right radial artery, and passed through the brachiocephalic artery and positioned along the greater curvature of the aorta. The device remained in position during the entire BAV procedure. “We were pleased to see how well the device tracked into the aorta and how easily it was positioned. It covered the orifice of the brachiocephalic, left common carotid and the left subclavian arteries,” said Dr. John Webb, director of cardiac catheterization and interventional cardiology, St. Paul’s Hospital. “There was no interaction with the device as we advanced several wires and catheters past the Embrella device enroute to the aortic valve.” The Embrella Embolic Deflector device is not available for clinical use in the United States. For more information: www.embrellacardiovascular.net

Related Content

Abbott Initiates First Clinical Trial of Clip-Based Tricuspid Repair System
News | Heart Valve Technology| August 09, 2017
Abbott announced that the first patient has been enrolled in a clinical study to evaluate a minimally invasive clip-...
The ChordArt transcatheter mitral valve leaflet chord replacement system on X-ray, showing the anchoring sections of the artificial chord.

The ChordArt transcatheter mitral valve leaflet chord replacement system on X-ray, showing the anchoring sections of the artificial chord.

News | Heart Valve Technology| August 01, 2017
Aug.
Hitachi and West Virginia University Partner to Advance Left Ventricular Mechanical Function Evaluation
News | Cardiovascular Ultrasound| July 21, 2017
Hitachi Healthcare and the West Virginia University Heart and Vascular Institute announced the formation of a new...
Edwards Sapien 3 TAVR valve will be implanted in asymptomatic aortic stenosis patients in the EARLY TAVR Trial
Feature | Heart Valve Technology| July 14, 2017
July 14, 2017 — Morristown Medical Center, part of Atlantic Health System, has randomized the first patient in the wo
Ziosoft's PhyZiodynamics 4-D processing showing a replaced aortic valve

An example of Ziosoft's PhyZiodynamics 4-D processing showing a replaced aortic valve.

Technology | Computed Tomography (CT)| July 12, 2017
July 12, 2017 — At the 2017 annual meeting for the Society of Cardiovascular Computed Tomography (SCCT), Ziosoft show
Medtronic's CoreValve Evolut R gained FDA approval for intermediate risk patients

An illustration of the self-expanding CoreValve Evolut R TAVR valve half deployed in the aortic root.

Feature | Heart Valve Technology| July 10, 2017
The U.S. Food and Drug Administration (FDA) has cleared an additional indication to expand the use Medtronic's self-...
HAART 300 Aortic Annuloplasty Device Sees U.S. Pilot Launch, First Commercial Use
News | Annuloplasty Rings| July 05, 2017
July 5, 2017 — BioStable Science & Engineering Inc.
Novel Approach May Improve Valve Function in Some Patients

Image courtesy of Messas, et al. JACC Basic to Translational Medicine.

News | Heart Valve Technology| June 30, 2017
June 30, 2017 — Pulsed cavitation ultrasound can be used to remotely soften human degenerative calcified biosprosthet
Overlay Init